COSTA MESA, Calif.--(BUSINESS WIRE)--Synthetic Blood International, Inc. (OTCBB:SYBD) announced today that Virginia Commonwealth University Reanimation Engineering Shock Center (VCURES) has received four separate research grants from the Office of Naval Research (ONR) totaling $3,517,696. These four grants will support pre-clinical research studies involving Oxycyte®, a product of Synthetic Blood International. Oxycyte is the company’s perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute.
